- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT07565376
Effects of Exercise-Induced Muscle Damage on Neuromuscular Complexity (EIMD-NMC)
Effects of Exercise-Induced Muscle Damage Induced by Eccentric Exercise on Knee Extensor Torque, Oxygenation, and Electromyographic Properties: A Complexity-Based Approach
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
The present study was designed to investigate the impact of exercise-induced muscle damage , caused by eccentric exercise, on neuromuscular and physiological function of the knee extensor muscles. The research was based on the contemporary theoretical framework of the "loss of complexity," which proposes that physiological signal variability is not merely random noise, but rather an essential characteristic of healthy and adaptable biological systems. According to this approach, greater signal complexity reflects a more flexible and efficient neuromuscular control strategy, whereas reduced complexity indicates impaired adaptability and a more rigid functional state.
A total of eleven healthy young men (N = 11, age 27.8 ± 2.5 years) participated in the study. During the initial session, anthropometric characteristics were recorded and maximal voluntary isometric torque of the knee extensors was measured. The main testing procedure involved a sustained submaximal isometric contraction performed at 50% of maximal voluntary contraction for 60 seconds. During this task, torque output, muscle oxygenation, and electromyographic activity of the vastus lateralis were continuously was recorded in order to assess both mechanical and neuromuscular responses.
Following baseline testing, participants completed a muscle damage induction protocol consisting of five sets of fifteen maximal eccentric contractions performed at an angular velocity of 60°/s. This protocol was designed to induce structural and functional muscle impairment characteristic of exercise induced muscle damage. Forty-eight hours after the intervention, all measurements were repeated to determine the effects of muscle damage on the same variables. Data were processed and analyzed in MATLAB, with statistical significance set at p < .05.
The results are anticipated to confirm the successful induction of muscle damage.
The investigators wanted to show the effect of exercise induced muscle damage on torque complexity through changes in Sample Entropy, and changes on detrended fluctuation analysis exponent, which indicate that torque fluctuations will became more regular, predictable, and less complex.
A possible reduction in complexity it expected to be accompanied by a change in neuromuscular efficiency, meaning that a greater level of neural activation will be needed to produce the same relative mechanical output. A likely explanation is that damage to muscle fibers and sarcomeres would reduce the effectiveness of force transmission, forcing the nervous system to compensate through increased neural drive.
In parallel, it is expected that muscle oxygenation measurements will show increased deoxygenated hemoglobin, indicating higher oxygen extraction and a greater metabolic burden on the remaining functional muscle fibers. This finding would suggest that, after exercise induced muscle damage, fewer intact fibers may be available to share the workload, thereby increasing the relative demand placed on those still functioning effectively.
An additional important observation will be the possible changes in traditional linear variability indices, such as standard deviation and coefficient of variation. This will highlight the limitation of conventional linear measures in detecting subtle but functionally meaningful changes in neuromuscular regulation.
Type d'étude
Inscription (Réel)
Phase
- N'est pas applicable
Contacts et emplacements
Lieux d'étude
-
-
Attica
-
Athens, Attica, Grèce, 17234
- School of Physical Education and Sport Science
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
- Adulte
Accepte les volontaires sains
La description
Inclusion Criteria:
- No experience of resistance exercise with heavy loads the past 6 months
Exclusion Criteria:
- History of lower-limb injury
- Taking any medication
- Suffered from any pathological condition
- Participation in a systematic eccentric exercise program during the previous 6 months
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Autre
- Répartition: Non randomisé
- Modèle interventionnel: Affectation à un seul groupe
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Eccentric exercise
All the parameters that was assessed 48 hours post isokinetic eccentric exercise
|
Isokinetic eccentric exercise consisted of 5 sets of 15 repetitions using the knee extensors.
The intensity of the exercise was the maximal voluntary and an interval of 1 minute was applied between sets.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Isokinetic sub maximal exercise
Délai: From enrollment to the end of the treatment at 48 hours
|
Isokinetic exercise of 60 seconds using the sub maximal intensity of 50% MVC.
The knee joint will be set at 90 degrees and the values will be in Nm.
|
From enrollment to the end of the treatment at 48 hours
|
|
Electromyography
Délai: From enrollment to the end of treatment at 48 hours
|
Continuous recording of EMG during the 60 seconds isometric exercise.
Patches will be placed in vastus laterals and the recording will be at 100 Hz
|
From enrollment to the end of treatment at 48 hours
|
|
Muscle oxygenation
Délai: rom enrollment to the end of treatment at 48 hours
|
Muscle oxygenation measured using near infrared spectroscopy (NIRS) of the knee extensors during the 60 seconds isometric exercise.
The main parameters that will be recored are the oxygenated haemoglobin, the deoxygenated haemoglobin, the total haemoglobin and the difference between oxygenated and deoxygenated haemoglobin.
|
rom enrollment to the end of treatment at 48 hours
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Delayed onset muscle soreness
Délai: From enrollment to the end of treatment at 48 hours
|
Assessment of subjective pain feeling assessed by palpation of knee extensors muscle belly.
The scale was set between 1 (no pain at all) to 10 (extreme pain).
|
From enrollment to the end of treatment at 48 hours
|
|
Range of Motion
Délai: From enrollment to the end of treatment at 48 hours
|
The angles the knee joint may be flexed without the feeling of any pain.
The starting position was set at full extension.
|
From enrollment to the end of treatment at 48 hours
|
|
Peak torque output
Délai: From enrollment to the end of treatment at 48 hours
|
Isometric peak torque output was assessed at 90 degrees knee joint angle (0 degrees was set at full extension).
The assessments was consisted of 3 set of 5 seconds each.
The higher performance was recorded for the data analysis
|
From enrollment to the end of treatment at 48 hours
|
Collaborateurs et enquêteurs
Les enquêteurs
- Chercheur principal: Vassilis Paschalis, Dr., National and Kapodistrian Univesity of Athens
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Autres numéros d'identification d'étude
- 1731/19-12-2024
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Description du régime IPD
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .